Affordable Access

deepdyve-link
Publisher Website

Hybridization-based antibody cDNA recovery for the production of recombinant antibodies identified by repertoire sequencing.

Authors
  • Valdés-Alemán, Javier
  • Téllez-Sosa, Juan
  • Ovilla-Muñoz, Marbella
  • Godoy-Lozano, Elizabeth
  • Velázquez-Ramírez, Daniel
  • Valdovinos-Torres, Humberto
  • Gómez-Barreto, Rosa E
  • Martinez-Barnetche, Jesús
Type
Published Article
Journal
mAbs
Publisher
Landes Bioscience
Publication Date
Jan 01, 2014
Volume
6
Issue
2
Pages
493–501
Identifiers
DOI: 10.4161/mabs.27435
PMID: 24492293
Source
Medline
Keywords
License
Unknown

Abstract

High-throughput sequencing of the antibody repertoire is enabling a thorough analysis of B cell diversity and clonal selection, which may improve the novel antibody discovery process. Theoretically, an adequate bioinformatic analysis could allow identification of candidate antigen-specific antibodies, requiring their recombinant production for experimental validation of their specificity. Gene synthesis is commonly used for the generation of recombinant antibodies identified in silico. Novel strategies that bypass gene synthesis could offer more accessible antibody identification and validation alternatives. We developed a hybridization-based recovery strategy that targets the complementarity-determining region 3 (CDRH3) for the enrichment of cDNA of candidate antigen-specific antibody sequences. Ten clonal groups of interest were identified through bioinformatic analysis of the heavy chain antibody repertoire of mice immunized with hen egg white lysozyme (HEL). cDNA from eight of the targeted clonal groups was recovered efficiently, leading to the generation of recombinant antibodies. One representative heavy chain sequence from each clonal group recovered was paired with previously reported anti-HEL light chains to generate full antibodies, later tested for HEL-binding capacity. The recovery process proposed represents a simple and scalable molecular strategy that could enhance antibody identification and specificity assessment, enabling a more cost-efficient generation of recombinant antibodies.

Report this publication

Statistics

Seen <100 times